Literature DB >> 23128018

Electrophysiological effects of acute atrial stretch on persistent atrial fibrillation in patients undergoing open heart surgery.

Arif Elvan1, Ahmet Adiyaman, Rypko J Beukema, Hauw T Sie, Maurits A Allessie.   

Abstract

BACKGROUND: The electrophysiologic effects of acute atrial dilatation and dedilatation in humans with chronic atrial fibrillation remains to be elucidated.
OBJECTIVE: To study the electrophysiological effects of acute atrial dedilatation and subsequent dilatation in patients with long-standing persistent atrial fibrillation (AF) with structural heart disease undergoing elective cardiac surgery.
METHODS: Nine patients were studied. Mean age was 71 ± 10 years, and left ventricular ejection was 46% ± 6%. Patients had at least moderate mitral valve regurgitation and dilated atria. After sternotomy and during extracorporal circulation, mapping was performed on the beating heart with 2 multielectrode arrays (60 electrodes each, interelectrode distance 1.5 mm) positioned on the lateral wall of the right atrium (RA) and left atrium (LA). Atrial pressure and size were altered by modifying extracorporal circulation. AF electrograms were recorded at baseline after dedilation and after dilatation of the atria afterward.
RESULTS: At baseline, the median AF cycle length (mAFCL) was 184 ± 27 ms in the RA and 180 ± 17 ms in the LA. After dedilatation, the mAFCL shortened significantly to 168 ± 13 ms in the RA and to 168 ± 20 ms in the LA. Dilatation lengthened mAFCL significantly to 189 ± 17 ms in the RA and to 185 ± 23 ms in the LA. Conduction block (CB) at baseline was 14.3% ± 3.6% in the RA and 17.3% ± 5.5% in the LA. CB decreased significantly with dedilatation to 7.4% ± 2.9% in the RA and to 7.9% ± 6.3% in the LA. CB increased significantly with dilatation afterward to 15.0% ± 8.3% in the RA and to 18.5% ± 16.0% in the LA.
CONCLUSIONS: Acute dedilatation of the atria in patients with long-standing persistent AF causes a decrease in the mAFCL in both atria. Subsequent dilatation increased the mAFCL. The amount of CB decreased with dedilatation and increased with dilatation afterward in both atria.
Copyright © 2013 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23128018     DOI: 10.1016/j.hrthm.2012.10.041

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  5 in total

Review 1.  Structural and Functional Remodeling of the Left Atrium: Clinical and Therapeutic Implications for Atrial Fibrillation.

Authors:  Rajeev Pathak; Dennis H Lau; Rajiv Mahajan; Prashanthan Sanders
Journal:  J Atr Fibrillation       Date:  2013-12-31

Review 2.  Post-operative Atrial Fibrillation - Pathophysiology, Treatment and Prevention.

Authors:  E Bidar; S Bramer; B Maesen; J G Maessen; U Schotten
Journal:  J Atr Fibrillation       Date:  2013-04-06

3.  The Electrophysiologic Effects of Acute Mitral Regurgitation in a Canine Model.

Authors:  Christopher P Lawrance; Matthew C Henn; Jacob R Miller; Michael A Kopek; Andrew J Zhang; Richard B Schuessler; Ralph J Damiano
Journal:  Ann Thorac Surg       Date:  2016-10-15       Impact factor: 4.330

4.  Increased thin filament activation enhances alternans in human chronic atrial fibrillation.

Authors:  Melanie A Zile; Natalia A Trayanova
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-24       Impact factor: 4.733

5.  Treatment of atrial fibrillation in patients with enhanced sympathetic tone by pulmonary vein isolation or pulmonary vein isolation and renal artery denervation: clinical background and study design : The ASAF trial: ablation of sympathetic atrial fibrillation.

Authors:  Mark R de Jong; Annemiek F Hoogerwaard; Ahmet Adiyaman; Jaap Jan J Smit; Anand R Ramdat Misier; Jan-Evert Heeg; Boudewijn A A M van Hasselt; Isabelle C Van Gelder; Harry J G M Crijns; Ignacio Fernández Lozano; Jorge E Toquero Ramos; F Javier Alzueta; Borja Ibañez; José M Rubio; Fernando Arribas; José M Porres Aracama; Josep Brugada; Lluís Mont; Arif Elvan
Journal:  Clin Res Cardiol       Date:  2018-02-27       Impact factor: 5.460

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.